Imipramine

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Thymoleptic, antidepressant.

IndicationThis section has been translated automatically.

Depressive syndromes regardless of their nosological classification, also long-term pain treatment.

Undesirable effectsThis section has been translated automatically.

Dermatologically significant: exanthema, photosensitivity, edema, hair loss, hyperhidrosis. Occasional increase of anxiety and agitation, turning into hypomania or mania, paresthesia, headache, in individual cases activation of psychotic symptoms, aggressiveness.

After at least 2 years of therapy, dyschromasia may occur in the exposed skin areas (complexation of imipramine with melanin). Successful treatments with the Q-switched alexandrite laser or the ruby laser have been described.

Remember! Active participation in road traffic is impaired.

ContraindicationThis section has been translated automatically.

Heart attack, do not administer ampoules together with diclofenac sodium inj. solution. Cave! Severe kidney disease or adrenal market tumor.

PreparationsThis section has been translated automatically.

Tofranil

Authors

Last updated on: 29.10.2020